About Pearl Diagnostics
Pearl Diagnostics is a private company based in Baltimore, Maryland, incorporated in 2022 in Delaware. It has reported $14,675,000 raised in two offerings on Form D since June 2022. Its chief executive is Eric Gornstein.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Apr 21, 2026 | $11,150,000fully sold | 21 | $530K | EquityRule 506(b) | Form D ↗ |
| Feb 23, 2022 | Jun 17, 2022 | $3,525,000fully sold | 11 | $320K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $14,675,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pearl Diagnostics's Form D filed Apr 21, 2026.
Brad Spellberg
Director
Kieren Marr
Founder and President, director
Also an executive officer and director at Elion Therapeutics.
Sources
- SECPearl Diagnostics, Inc. filing history
- CompanyContact Us
- CompanyAbout Us
- CompanyClinical studies announcement